Update in General Internal Medicine
Authors: Diane Altkorn, Keith Roach, Scott Stern, Wendy Levinson
Journal: Annals of Internal Medicine (1999)

Updates from the Annual Session3 August 1999Update in General Internal MedicineDiane Altkorn, MD, Keith Roach, MD, Scott Stern, MD, and Wendy Levinson, MDDiane Altkorn, MDFrom University of Chicago Pritzker School of Medicine and University of Chicago Medical Center, Chicago, Illinois.Search for more papers by this author, Keith Roach, MDFrom University of Chicago Pritzker School of Medicine and University of Chicago Medical Center, Chicago, Illinois.Search for more papers by this author, Scott Stern, MDFrom University of Chicago Pritzker School of Medicine and University of Chicago Medical Center, Chicago, Illinois.Search for more papers by this author, and Wendy Levinson, MDFrom University of Chicago Pritzker School of Medicine and University of Chicago Medical Center, Chicago, Illinois.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-131-3-199908030-00007 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail We selected the articles for this Update in General Internal Medicine on the basis of two criteria: 1) Was the study methodologically rigorous? 2) Will the article change how we diagnose conditions or treat our patients? We focus on articles in 10 subcategories: cancer, stroke and atrial fibrillation, venous thromboembolism, cardiology, gastroenterology, diabetes, osteoporosis, hormone replacement therapy, geriatrics, and headache. Although a small number of these articles may be described again in other Updates in the 1999-2000 Update Series, they are featured here to highlight their importance and to convey a composite of advances in general internal medicine.CancerThree ...References1. Powles T, Eels R, Ashley S, Easton D, Chang J, Dowsett M, et al . Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet. 1998;352:98-101. CrossrefMedlineGoogle Scholar2. Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, et al . Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomized women. Italian Tamoxifen Prevention Study. Lancet. 1998;352:93-7. CrossrefMedlineGoogle Scholar3. Bjurstam N, Bjornfeld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, et al . The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer. 1997;80:2091-9. CrossrefMedlineGoogle Scholar4. . Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-57. CrossrefMedlineGoogle Scholar5. Miettinen TA, Pyorala K, Olsson AG, Musliner TA, Cook TJ, Faergeman O, et al . Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation. 1997;96:4211-8. CrossrefMedlineGoogle Scholar6. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al . Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med. 1998;338:727-34. CrossrefMedlineGoogle Scholar7. Rao PM, Rhea JT, Novelline RA, Mostafavi AA, McCabe CJ. . Effect of computed tomography of the appendix on treatment of patients and use of hospital resources. N Engl J Med. 1998;338:141-6. CrossrefMedlineGoogle Scholar8. . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703-13. CrossrefMedlineGoogle Scholar9. . Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ. 1998;317:713-20. CrossrefMedlineGoogle Scholar10. Buse JB, Gumbiner B, Mathias NP, Nelson DM, Faja BW, Whitcomb RW, et al . Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study Group. Diabetes Care. 1998;21:1455-61. CrossrefMedlineGoogle Scholar11. Horton ES, Whitehouse F, Ghazzi MN, Venable TC, Whitcomb RW. Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group. Diabetes Care. 1998;21(9):1462-9. CrossrefGoogle Scholar12. Gitlin N, Julie NL, Spurr CL, Lim KN, Juarbe HM. . Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone. Ann Intern Med. 1998;129:36-8. LinkGoogle Scholar13. Neuschwander-Tetri BA, Isley WL, Oki JC, Ramrakhiani S, Quiason SG, Phillips NJ, et al . Troglitazone-induced hepatic failure leading to liver transplantation. A case report. Ann Intern Med. 1998;129:38-41. LinkGoogle Scholar14. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selection serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998;351:1303-7. CrossrefMedlineGoogle Scholar15. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338:1397-404. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From University of Chicago Pritzker School of Medicine and University of Chicago Medical Center, Chicago, Illinois.Corresponding Author: Wendy Levinson, MD, University of Chicago Pritzker School of Medicine, 5841 South Maryland Avenue, MC 6098, Chicago, IL 60637.Current Author Addresses: Drs. Altkorn, Roach, and Stern: University of Chicago Medical Center, 5841South Maryland Avenue, MC 3051, Chicago, IL 60637.Dr. Levinson: University of Chicago Pritzker School of Medicine, 5841 South Maryland Avenue, MC 6098, Chicago, IL 60637. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoStandardization of Hemoglobin A1c Values Meera Jain , Anthony McCall , and Matthew Riddle Metrics Cited ByStandardization of Hemoglobin A1c ValuesMeera Jain, MD, Anthony McCall, MD, PhD, and Matthew Riddle, MDUpdate in Hospital MedicineFranklin A. Michota Jr, MDUpdate in Women's HealthPamela Charney, MD, Judith Walsh, MD, MPH, and Ann B. Nattinger, MD, MPHUpdate in CardiologyMelvyn Rubenfire, MD 3 August 1999Volume 131, Issue 3Page: 199-206KeywordsBreast cancerCholesterolDrugsHemorrhageHormone replacement therapyInsulinNumber needed to treatStable coronary artery diseaseStrokeType 2 diabetes Issue Published: 3 August 1999 CopyrightCopyright © 1999 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...